Tranexamic Acid Reduces Blood Loss in Off-Pump Coronary Artery Bypass Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 3, 2009, Pages 312-315

  Taghaddomi, Reza Jalaeian ^a   Mirzaee, Asadollah ^b   Attar, Alireza Sharifian ^a   Shirdel, Abbas ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

hemostasis; off pump coronary artery bypass; tranexamic acid

Indexed keywords

DIAZEPAM; FENTANYL; MIDAZOLAM; MORPHINE; PANCURONIUM BROMIDE; PROPOFOL; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

EID: 67349151288     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.09.018     Document Type: Article

References (27)

1. Iaco A.L., Contini M., Teodori G., et al. Off or on bypass: What is the safety threshold?. Ann Thorac Surg 68 (1999) 1468-1469
2. Cartier R., Brann S., Dagenais F., et al. Systematic off-pump coronary artery revascularization multivessel disease: Experience of three hundred cases. J Thorac Cardiovasc Surg 119 (2000) 221-229
3. Nader N.D., Reich N.T., Khadra W.Z., et al. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques. Ann Thorac Surg 68 (1999) 1640-1643
4. Barrons R.W., and Jahr J.S. A review of post-cardiopulmonary bypass bleeding, aminocaproic acid, tranexamic acid, and aprotinin. Am J Ther 3 (1996) 821-838
5. Laupacis A., and Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. The International Study of Perioperative Transfusion (ISPOT) Investigators. Anaesth Analg 85 (1997) 1258-1267
6. Wong B., McLean R.F., Fremes S.E., et al. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg 69 (2000) 808-816
7. Andreasen J.J., and Nielsen C. Prophylactic tranexamic acid in elective, primary coronary bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg 26 (2004) 311-317
8. Brown J.R., Birkmeyer N.J.O., and O'Connor G.T. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115 (2007) 2801-2813
9. Fergusson D.A., Hebert P.C., Mazer C.D., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
10. Casati V., Gerli C., Franco A., et al. Tranexamic acid in off-pump coronary surgery: A preliminary, randomized, double-blind, placebo-controlled study. Ann Thorac Surg 72 (2001) 470-475
11. Vanek T., Jares M., Fajt R., et al. Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study. Eur J Cardiothorac 28 (2005) 563-568
12. Wei M., Jian K., Guo Z., et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scand Cardiovasc J 40 (2006) 105-190
13. Jares M., Vanek T., Straka Z., et al. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. J Cardiovasc Surg (Torino) 44 (2003) 205-208
14. Casati V., Della Valle P., Benussi S., et al. Effects of tranexamic acid in postoperative bleeding and related hematological variables in coronary surgery: Comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 128 (2004) 83-91
15. van Dijk D., Nierich A.P., Jansen E.W., et al. Early outcome after off-pump versus on-pump coronary bypass surgery: Results from a randomized study. Circulation 104 (2001) 1761-1766
16. Ascione R., Lloyd C.T., Underwood M.J., et al. Economic outcome of off-pump coronary artery bypass surgery: A prospective randomized study. Ann Thorac Surg 68 (1999) 2237-2242
17. Mangano D.T., Tudor I.C., Dietzel C., Multicenter Study of Perioperative Ischemia Research Group, and Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
18. Mangano D.T., Miao Y., Vuylsteke A., et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007) 471-479
19. Ruel M.A., Wang F., Bouker M.E., et al. Is tranexamic acid safe in patients undergoing coronary endarterectomy?. Ann Thorac Surg 71 (2001) 1508-1511
20. Kareski J., Djaiani G., Carroll J., et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: A prospective randomized controlled clinical trial. J Thorac Cardiovasc Surg 130 (2005) 309-314
21. Levi M., Cromheecke M.E., de Jonge E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints. Lancet 354 (1999) 1940-1947
22. Biglioli P., Cannata A., Alamanni F., et al. Biological effects of off-pump vs. on-pump coronary artery surgery: Focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 24 (2003) 260-269
23. Hekmat K., Zimmermann T., Kampe S., et al. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: A prospective, randomized, double-blind trial. Curr Med Res Opin 20 (2004) 121-126
24. Smith P.K., and Muhlbaier L.H. Aprotinin: Safe and effective only with the full dose regimen. Ann Thorac Surg 62 (1996) 1575-1577
25. Cosgrove D.M., Heric B., Lytle B.W., et al. Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 54 (1992) 1031-1038
26. Lemmer J.H., Dilling E.W., Morton J.R., et al. Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens. Ann Thorac Surg 62 (1996) 1659-1667
27. Alderman E.L., Levy J.H., Rich J.B., et al. Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trial. J Thorac Cardiovasc Surg 116 (1998) 716-730